Development and delivery of the immunoscintigraphic agent 67Ga-MILGA (Miltuximab™) for a first-in-human phase 1 clinical trial

N Lengkeek, M Roberts, T Pham, S Wissmeuller, D Campbell, B Walsh, Q Truong, I Greguric, J Wong, C Chandler, A Winthorpe, R Sheth, M Calvi, A Bowan, A Hawes

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)13
Number of pages1
JournalInternal Medicine Journal
Issue numberS3
Publication statusPublished - Apr 2018
Externally publishedYes
EventAnnual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (48th : 2018) - Melbourne, Australia
Duration: 21 Apr 201824 Apr 2018

Cite this